BodyTel Scientific Announces the Formation of BodyTel Europe GmbH.HENDERSON, Nev. -- BodyTel Scientific, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). : BDYT), a company focused on the development of innovative wireless healthcare products, announced the formation of BodyTel Europe GmbH, a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. of BodyTel Scientific, Inc., in Bad Wildungen, Germany. BodyTel Europe will serve as the center for all sales and marketing related functions for Europe, the Middle East and Africa Europe, the Middle East and Africa, usually abbreviated to EMEA, is a regional designation used for government, marketing and business purposes. It is particularly common amongst North American based companies, who often divide their international operations into the (EMEA (Europe, Middle East, Africa) Refers to that region of the world. For example, one might see products packaged differently for the UK, EMEA and Asia Pacific markets. ). Stefan Schraps, Chief Executive Officer and President of BodyTel Scientific, Inc., will be based at the new office and will serve as CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. (Geschaeftsfuehrer) of the limited liability company under German law. BodyTel Europe has begun recruiting qualified sales and administrative personnel for the upcoming launch of GlucoTel, the first and only diabetes self-management system with integrated Bluetooth. Management believes, based on the development of the GlucoTel system, that now is an opportune op·por·tune adj. 1. Suited or right for a particular purpose: an opportune place to make camp. 2. Occurring at a fitting or advantageous time: an opportune arrival. time to start hiring a competent sales and marketing team. BodyTel Scientific, Inc., CEO, Stefan Schraps, commented, "We are making tremendous strides in the development of our GlucoTel product and we are confident to be on schedule for product launch in Fall 2007. With the launch of our product nearing, and as worldwide partnerships are executed, it is extremely important that our European presence be firmly established." The GlucoTel Meter is the first and only blood glucose monitoring blood glucose monitoring Sugar monitoring Lab medicine The periodic testing of serum glucose in Pts known to have DM. See Bedside glucose monitoring, Beta cell implants, Diabetes, Glucometer, Glycosylated hemoglobin, Non-Invasive glucose monitoring. device in the world with integrated Bluetooth(TM) technology. The meter is part of the GlucoTel system, which is a complete telemedical diabetes self-management system supporting patients and doctors in the treatment of diabetes and its secondary complications. The GlucoTel blood glucose blood glucose Diabetology The principal sugar produced by the body from food–especially carbohydrates, but also from proteins and fats; glucose is the body's major source of energy, is transported to cells via the circulation and used by cells in the presence meter collects blood sugar readings and sends them to the patient's mobile phone via Bluetooth. Afterwards af·ter·ward also af·ter·wards adv. At a later time; subsequently. afterwards or afterward Adverb later [Old English æfterweard] Adv. 1. , the data is automatically sent to a secure Internet database via SMS (1) (Storage Management System) Software used to routinely back up and archive files. See HSM. (2) (Systems Management Server) Systems management software from Microsoft that runs on Windows NT Server. and is centrally held there long-term. GlucoTel enables involvement of the patients in the treatment of diabetes, thereby improves the information basis and communication between doctor and patient and thus contributes to the course of therapy. About BodyTel Scientific, Inc. BodyTel Scientific, Inc. is a company focused on the development of innovative wireless health monitoring products. Please visit www.bodytel.com for more company information. Forward-Looking Statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. Statements regarding the Company's business which are not historical facts are "forward-looking statements" that involve risks and uncertainties that could cause actual results to differ materially from the potential results discussed in the forward-looking statements. Forward-looking statements in this press release include that BodyTel Europe will serve as the center for all sales and marketing related functions for Europe, the Middle East and Africa, that Management believes, based on the development of the GlucoTel system, that now is an opportune time to start hiring a competent sales and marketing team, and that we are confident to be on schedule for product launch in Fall 2007. Actual results may differ materially from those currently anticipated due to a number of factors as we may find that our products must compete with cheaper or better products; we may not be able to retain key employees; a bigger market may not develop for our products and we may not be able to continue to attract new customers; we may face litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. if our technology fails to work when required; our intellectual property may be attacked and defeated in court proceedings; our patent and FDA/CE filings may be rejected by the patent offices and regulators; other companies may discover and develop better or cheaper technologies that would render our products obsolete and we may not have sufficient funding to further develop and/or market our technology. Readers are directed to the BodyTel Scientific, Inc.'s reports as filed with the U.S. Securities and Exchange Commission from time to time, including but not limited to its 8-K filed December 14, 2006 under our prior name Sellcell.net which outlined the company's current business for further information and factors that may affect BodyTel Scientific Inc.'s business and results of operations as well as the Company's form 10-KSB filed on June 20, 2007. BodyTel Scientific Inc. undertakes no obligations to publicly update any forward-looking statements to reflect future events or circumstances. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion